The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...
Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...
Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
Itchy feet can be a sign of various medical conditions, including liver disease, diabetes, and kidney disease - here's what ...
Tivozanib plus nivolumab had similar patient-reported outcomes to tivozanib alone in advanced kidney cancer after prior treatment, according to the TiNivo-2 study.
Symptom scores remained stable over time, with similar QOL trends in both treatment arms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results